(PharmaNewsWire.Com, January 07, 2020 ) According to the new market research report Single-use Bioreactors Market is expected to grow at a CAGR of 21.9% from 2017 to 2022, to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017. In the current market scenario, there is a growing demand for single-use bioreactor products. The major factors driving the growth of the Single Use Bioreactors include the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in cultivating marine organisms, and reduced impact on the environment.
The single-use bioreactors market is segmented based on product type, cell type, technology, application, end user, and region.
Based on product type, the market is segmented into monoclonal antibodies, vaccines, gene-modified cells, recombinant proteins, stem cells, and other products (growth factors, interferons, and antisense DNA & RNA). Among the above-mentioned product segments, the stem cells segment is estimated to witness the highest growth during the forecast period. The high growth in this segment can be attributed to advantages such as reduced medium consumption, ease of use, and the ability to monitor process parameters and cell health.
Research & Development is expected to be the Fastest-growing Application Segment in the Single-use Bioreactors Market
Thermo Fisher Scientific, Inc (U.S.) Held the Leadership Position in the SUB in 2014 Owing to Its Broad Product Portfolio and Strong Brand Name
Thermo Fisher Scientific, Inc. will hold the leadership position in the Single Use Bioreactors Market in 2014. The company has an extensive product portfolio, including bioreactors such as open architecture bioreactor systems, turnkey bioreactor systems, and bioreactor accessories. The company has a good reputation and a strong customer base for its SUBs. Sartorius AG holds the second-largest share. It is a leading provider of laboratory equipment and process technologies and has a vast product portfolio that has helped it to maintain its position in the Single Use Bioreactors Market.
The Single Use Bioreactors Market is highly consolidated, with the top five players accounting for a share of more than 75%. The major players include Thermo Fischer Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), GE Healthcare (U.S.), and Pall Corporation (U.S.).
Collaboration is the most preferred strategy adopted by key players in this market. Players adopted this strategy to enhance their product offerings, increase their market share, cater to the customers’ demands, and consolidate their market presence. The wave-induced motion SUBs and stirred SUBs product segments of this market have emerged as revenue-generating pockets in countries such as the U.S., India, and China.
The Europe is expected to account for the largest share of the single-use bioreactors market in 2016. Government support for new biologics has encouraged the research and development of biologics. North America is accounted for the second-largest share of the single-use bioreactors market. The key players in the single-use bioreactors market are Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US).
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 newsletter@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
